On the control of acute rodent malaria infections by innate immunity by Yates, Andrew J. et al.
nn 
 
 
 
 
Yates, A. J., Kochin, B. F., de Roode, J. C., and Antia, R. (2010) On the 
control of acute rodent malaria infections by innate immunity.PLoS ONE, 5 
(5). e10444. ISSN 1932-6203 
 
Copyright © 2010 The Authors 
 
http://eprints.gla.ac.uk/100336/  
 
 
 
 
 
Deposited on:  11 December 2014 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
On the Control of Acute Rodent Malaria Infections by
Innate Immunity
Beth F. Kochin*, Andrew J. Yates¤, Jacobus C. de Roode, Rustom Antia
Department of Biology, Emory University, Atlanta, Georgia, United States of America
Abstract
Does specific immunity, innate immunity or resource (red blood cell) limitation control the first peak of the blood-stage
parasite in acute rodent malaria infections? Since mice deficient in specific immunity exhibit similar initial dynamics as wild-
type mice it is generally viewed that the initial control of parasite is due to either limitation of resources (RBC) or innate
immune responses. There are conflicting views on the roles of these two mechanisms as there is experimental evidence
supporting both these hypotheses. While mathematical models based on RBC limitation are capable of describing the
dynamics of primary infections, it was not clear whether a model incorporating the key features of innate immunity would
be able to do the same. We examine the conditions under which a model incorporating parasite and innate immunity can
describe data from acute Plasmodium chabaudi infections in mice. We find that innate immune response must decay slowly
if the parasite density is to fall rather than equilibrate. Further, we show that within this framework the differences in the
dynamics of two parasite strains are best ascribed to differences in susceptibility to innate immunity, rather than differences
in the strains’ growth rates or their propensity to elicit innate immunity. We suggest that further work is required to
determine if innate immunity or resource limitation control acute malaria infections in mice.
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Introduction
Understanding what controls the initial decline in pathogen
density during the acute phase of infections is an important and
largely unsolved problem. Three mechanisms may cause this
decline: (i) the specific immune responses of the host; (ii) the innate
immune response of the host; and (iii) the availability of resources,
such as target cells, that are required for pathogen replication.
During the acute phase of primary malaria infection the parasite
grows exponentially to a high density through replication in red
blood cells (RBCs), and subsequently declines. Different malaria
strains reach different peak densities in this phase. The dynamics
then become much more complex, and are strongly influenced by
the interplay between specific immune responses and antigenic
variation which allows the parasite to evade these specific
responses [1–5].
Because of the wealth of data available on the early dynamics of
parasite and RBCs in mice infected with Plasmodium chabaudi, we focus
on this system. Specific immunity is unlikely to be controlling parasite
growth during the acute phase of infection in this system. Mice
lacking B or T cells exhibit early parasite dynamics that are very
similar to those in wild type mice [6–9]. This observation leaves us
with the resource limitation and innate immunity hypotheses.
Many theoretical studies have proposed that RBC limitation
determines the acute parasite dynamics [10–15], but this
viewpoint is supported by relatively little experimental data [16].
In this scenario the transient exhaustion of susceptible RBC causes
the first decline in parasite numbers in the blood. Gupta et al. [10]
introduced the possibility that RBC limitation played a major role
during the initial stages of infection. McQueen and McKenzie
[12] explored the consequences of allowing the parasite to infect
only a limited subset of RBCs (of a specific age range). Antia et al.
[14] and Mideo et al. [15] showed how the RBC limitation models
could describe the dynamics of infection of mice with P. chabaudi.
However, the ability of a model to describe the data does not make
it correct.
In contrast, the predominant view in the experimental literature
is that innate immunity is responsible for the initial control of
infection [see, for example, [17–20]]. For example, mice lacking
IFN-c are not able to control the initial infection as well as wild
type mice and often die [21,22]. While a few pioneering
theoretical studies explored how innate immunity may affect the
dynamics of malaria infections [23–25], none of them has
considered whether innate immunity can describe the early
dynamics of infections with Plasmodium chabaudi. One major
difficulty to overcome is our lack of a detailed quantitative
understanding of the innate immune response. For example, the
functional form of the innate immune response terms in the study
by Dietz et al. [24] does not allow for a decline in parasitemia after
the maximum parasitemia is reached. The study by Haydon et al.
[23] does not include a decay term for the innate immune
response, and so this alone would drive the parasite density to zero
following the initial peak. The study by McQueen and McKenzie
[25] considers how the incorporation of innate and specific
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immunity alters the dynamics observed in an RBC-limited model,
but does not discuss whether innate immunity alone can explain
the initial dynamics. This is the question that we address in this
paper.
We consider a detailed dataset on the timecourse of infections of
inbred mice with the AS and AJ strains of Plasmodium chabaudi
[26–28]. In these experiments mice were infected with AS or AJ
alone, or were co-infected with both. Co-infection was done in
three ways: the strains were administered simultaneously, or one
strain was given three days before the other. In single-strain
infections, AJ reached higher densities and caused greater anemia
than strain AS; in the co-infection experiments, AJ outcompeted
AS. Previously, we showed that these data can be explained using
a resource-limitation model [14] in which AJ is able to infect a
larger proportion of red blood cells than AS. In this paper we
determine if a model of parasite dynamics controlled by the innate
immune response alone can also explain the data. We will also
identify the factors underlying the different dynamics of the two
strains in this (innate immunity) model.
Methods
The model consists of equations for the density of parasite, P,
and the magnitude of the innate immune response, I . In accord
with previous models, we let P be the density of infected RBCs
[3,24,29].
We focus on the role of innate immunity, rather than other
factors such as RBC limitation, in the control of the parasite.
Consequently, we assume the parasite grows exponentially (at rate
r) in the absence of innate immunity. This is predicted by the
resource-limitation models if RBCs are in abundance and is a
simple consequence of the repeated rounds of amplification of
parasite number resulting from infection and bursting of RBCs.
We let the magnitude of the innate immune response to the
parasite, I , be the number of activated innate immune cells (e.g.
phagocytic cells such as macrophages and dendritic cells). These
cells produce inflammatory cytokines such as IFN-c, TNF-a and
IL-12 which have been shown to be upregulated following
infection [21,30–32].
A robust model of the innate immune response should include
three key features which distinguish it from the adaptive (or
antigen-specific) response [33]. First, innate immunity is depen-
dent on the direct activation or recruitment of effector cells and
consequently can be elicited more rapidly than the adaptive
immune response, which involves cell proliferation by clonal
expansion. Second, while recruitment is faster than replication,
this limits the maximum magnitude of the innate response. Finally,
innate immunity does not exhibit long-term memory – its
magnitude decays in the absence of continued stimulation.
We let the total number of cells of the innate immune system be
constant at j, and the induction of an innate immune response is
through the recruitment and/or activation of these cells rather
than their proliferation or clonal expansion. The number of resting
innate immune cells thus equals j{I . We use a mass-action term
for the activation of these resting cells by exposure to the parasite,
with rate constant a. Activated innate immune cells clear infected
RBCs at rate kP (by phagocytosis, reactive oxygen or other
methods). Activated cells become inactivated at rate d. This model
is shown schematically in Figure 1.
_I(t)~aP(t)(j{I(t)){dI(t),
_P(t)~rP(t){kI(t)P(t):
ð1Þ
This model can be extended to consider co-infections with two
parasite strains, PAJ and PAS as follows:
_I(t)~(aASPAS(t)zaAJPAJ (t))(j{I(t)){dI(t)
_PAS(t)~rASP(t){kASI(t)PAS(t)
_PAJ (t)~rAJP(t){kAJI(t)PAJ (t)
ð2Þ
Without loss of generality we can scale the maximum level of
innate immunity, j to unity. In our analysis we set the decay rate
d~0:3 day{1, representing a half-life for the decay of the innate
immune response in the absence of stimulus (ln 2=d) of
approximately two days (see File S1, section 1). The remaining
parameters (r, a and k) are estimated using the data from single
infections with AS or AJ by minimizing the residual sum of
squares. We then use these parameter values to predict the
outcome of mixed infections as in Antia et al. [14].
In File S1, section 2, we show how the dynamics arising from
this simple model of parasite growth and clearance in the blood
are indistinguishable from those obtained with a fuller description
of RBC infection and dynamics.
Results
We compare the model predictions to data from experiments
measuring parasite density of the AS and AJ strains of P. chabaudi
following infection of C57BL/6 mice as described in the
introduction.
We begin with single infections (Figure 2, a–d). We see that the
model (eqns. (1)) can describe the basic features of single infections
– an initial exponential growth and subsequent control of the
parasite. We then explore how differences in the model parameters
for different strains can affect the peak parasite density, by
allowing AS and AJ to differ in only a single parameter.
Differences in peak parasite density between the two strains might
be explained by differences in the following parameters of the
model: (i) r, the growth rate; (ii) a, the rate constant for eliciting
immunity; or (iii) k, the rate of clearance by the innate immune
response. We note that the parameter j, which describes the
maximum magnitude of innate immunity (which may be thought
of in this case to equal the total number of phagocytic cells)
Figure 1. Schematic of model. In our model the density of the
parasite, P, depends on two factors – its own replication (at rate r) and
its clearance by activated innate immune cells I at rate kI . The total
number of innate immune cells equals j and they can be either in a
resting or activated state. Since I is the number of activated cells, the
number of resting cells equals (j{I). Resting innate immune cells are
activated at rate aP, and revert back to the inactive state at exponential
rate d .
doi:10.1371/journal.pone.0010444.g001
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depends on the host and not the parasite strain. We find that AJ
reaches a higher density than AS if it has a higher growth rate
(rAJwrAS: Figure 2, b), a lower rate of eliciting innate immunity
(aAJvaAS : panel c), or a lower rate of being killed by innate
immunity (kAJvkAS: panel d). Fitting on days 2–10 after
infection, we find that any one of these three possibilities is about
equally good at explaining the single infection data (the residual
sum of squares is very similar). After day 10, the observed parasite
densities are lower then predicted by the model. This is not
surprising since we do not include specific immunity which likely
acts to control the parasite after day 10.
We then consider the competition between AJ and AS in hosts
simultaneously infected with both strains (Figure 2, e–h). Using
the parameters obtained from the single infection data we predict
the outcome of simultaneous infections. We find that a difference
in growth rate will allow the faster growing strain, AJ, to
outcompete the slower growing parasite strain, AS (panel f). This
is because the AJ strain will reach a higher density prior to both
strains being controlled at the same rate by the innate immune
response. We see a similar result following co-infection of a host
when AJ and AS differ in their susceptibility to innate immunity
(panel h). If, however, the strains differ in the rate at which they
elicit innate immunity we get a different result. In this case the
model predicts no competitive advantage for AJ if it simply
activates the innate immune response at a slower rate then AS
(panel g). This can be understood intuitively – in simultaneous
infections the innate immune response clears both strains equally,
irrespective of which strain elicits it most potently.
Little new insight is gained by looking at the model predictions
for sequential infections. As in the case of co-infections the
Figure 2. Experimental data and models for the dynamics of strains AS (red dashed lines) and AJ (blue solid lines). We use the model
described in the text to investigate whether the dynamics of AS and AJ could be explained by (I) AJ having a higher growth rate than AS; (II) AJ
inducing innate immunity more slowly than AS; or (III) AJ being less susceptible to killing by innate immunity than AS. Host Parameters: I(0)~0 (that
is, no innate immunity is activated at infection), d~0:3 day{1 and j~1. Strain parameters are estimated using the single infection data from days 2–
10 only (unshaded area). Strain parameters, I: P(0)~32 cells, rAJ~1:94 day
{1 , rAS~1:76 day
{1 , a~1:35|10{8 days{1cells{1, k~108 day{1 . II:
P(0)~31 cells, r~1:85 day{1, aAJ~9:20|10
{9 days{1cells{1 , aAS~1:17|10{8 days{1cells{1 , k~139. III: P(0)~31 cells, r~1:85 day{1,
a~1:22|10{8 days{1cells{1 , kAJ~106 day{1 , kAS~133 day{1 . The left-hand column shows the mean parasite counts over time from
experimental data for single infections (panel a; n = 11 (AJ) and n= 14 (AS)) and co-infections (panels e, i, m; n = 4, 4 and 5 respectively).
doi:10.1371/journal.pone.0010444.g002
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experimental results (panels i, m) show that AJ outcompetes AS
(the ratio of AJ/AS increases, particularly when AS is present prior
to AJ). This can be seen in simulations if the strains differ in either
their growth rate or the rate they are killed by the innate immune
response, but not if they differ only in the rates at which they
activate innate immunity.
Caution is needed when interpreting parameter values. The
parameters a (activation rate) and k (killing rate) are degenerate as
described in File S1, section 3. In other words multiple
combinations of a and k give the same dynamics.
In summary, our results indicate that control by innate immunity
can explain the dynamics of AJ and AS in single andmixed infections.
We note that a difference in the rate at which AJ and AS elicit
immunity (a) alone does not give rise to the observed competition
dynamics in this model; there must also be a difference in either
growth rate r or susceptibility to innate immunity k. However, by
estimating parasite growth rates using infected cell data from days 2, 3
and 4 only we found no significant difference in the growth rates of
AS and AJ (mean + standard deviation: rAS~1:98+0:42 day{1,
rAJ~2:11+0:60 day{1; t-test, p~0:55), suggesting susceptibility to
immunity is the most likely factor underlying strain differences in the
innate immune control hypothesis.
Discussion
This study explores one hypothesis for the control of the dynamics
of acute malaria infections – that the innate immune system is
responsible for the initial control of the parasite density in blood.
We have intentionally used a simple model. Much remains to be
done to quantify innate immune responses experimentally, and
there have been relatively few attempts to model them in detail. As
a first approximation, we have modeled the immunostimulatory
force as the number of infected cells and equated the magnitude of
the innate immune response with the number of activated
macrophages and other phagocytic cells. In this picture the
activated phagocytes work by killing infected RBCs. Despite its
simplicity, our model provides surprisingly close agreement with
the qualitative features of the experimental data. As we obtain a
better quantitative description of innate immune responses and
independent estimates for the different parameters we hope to be
able to make quantitative predictions.
We find that interaction between parasite growth and the innate
immune system can indeed give rise to dynamics similar to those
observed during acute infections of naive hosts. However this requires
that the rate of decay of innate immunity is not too fast (we need a half
life of days rather than hours). It is perhaps not very surprising that
within certain parameter regions the model can generate the
observed dynamics. Exponential growth followed by a contraction
phase can be fitted by a multitude of models. Also, there are a large
number of free parameters due to our lack of detailed understanding
of the dynamics of the innate immune response and its interaction
with the malaria parasite. This highlights the importance of obtaining
independent estimates for as many of the parameters as possible. For
example, if an independent estimate for the decay rate of innate
immunity was very fast giving a half-life of less then one day, we could
reject this model.
Our model allows parasite strains to differ in three ways – their
initial growth rate, the rate at which they stimulate innate
immunity and their susceptibility to innate immunity. We use our
model to understand the differences between AS and AJ strains of
P. chabaudi. Our results suggest that AJ, which reaches higher
densities and outcompetes AS, either grows faster than or is more
resistant to innate immunity than AS. The data give more support
to the latter explanation.
In an earlier study Antia et al. [14] showed that a resource
limitation model could explain the data described in this paper.
Here we show that innate immunity can also reproduce the
observed dynamics. We note that there are some minor aspects of
the data that seem to be better described by one model or the
other. When AS is given before AJ (Figure 2, panel i), the resource
limitation model seems to better describe the switch from AS to AJ
parasite dominance. However, we do not think this is significant
enough to make one model more likely then the other. Indeed we
feel that modeling alone may not be sufficient to convincingly
discriminate between different biological hypotheses. The process
of making models forces us to make explicit what are frequently
vaguely formed assumptions regarding the underlying biology, and
these assumptions can impact on model discrimination. Multiple
variations are possible in the innate immunity framework
presented here, while preserving the three key biological features
of the model. For example, activation or killing rates might
saturate as functions of pathogen or immune effector densities; and
different arms of the innate immune response might be directed at
infected RBCs and at free merozoites. Correspondingly, there are
many plausible variations within the RBC limitation framework.
When making RBC limitation models we are forced to ask how
RBCs differ in their susceptibility to infection and their response
following infection. We previously assumed that a single discrete
age-range of RBCs was susceptible to infection [14]; some
variations include continuously variable or even bimodal suscep-
tibility of RBCs to infection as a function of age, or differences in
the fecundity of infected RBCs with age.
There are two ways in which further studies could discriminate
between the resource limitation and innate immunity models for P.
chabaudi infections. One approach involves computing the relative
levels of support for different models. In this case, where we do not
know the exact forms of the terms of the resource limitation or
innate immunity this approach would involve comparing families
of different innate immunity and resource limitation models. The
advantage of this approach is that it could be undertaken with the
existing data. The main problem with this approach is that while
we have a reasonable quantitative biological understanding of
resource limitation we have a much poorer basic quantitative
understanding of innate immunity. We are not certain to have,
even in the broader family of models, sufficiently accurate terms
for innate immunity.
The alternative is further experimental studies to tease out more
cleanly the relative contributions of resource limitation or innate
immunity. In this view, further progress is most likely with
experiments that test predictions that are independent of the
details of the underlying models. Models, by forcing rigorous
thought and explicit consideration of the assumptions behind
verbal arguments might aid the design of key experiments.
The data used in this study comes from C57Bl/6 mice infected
with two strains of P. chabaudi. However, provided the mice
survive the acute phase on infection, qualitatively similar early
dynamics (exponential growth followed by a decline) are observed
following infections with different strains of parasite (such as P.
berghei, and non-lethal P. yoelli) and host (such as BALB/c and
C57Bl/10) [31,34,35].
We note that we do not consider adaptive immune responses.
For the two strains of a rodent malaria examined here, the
contribution of adaptive immune responses only becomes
significant well after the acute parasitemia has peaked [6–9].
The timescales of infection in human malaria are different and
specific immunity may well contribute to the control of the first
peak in parasitemia [25,36]. The P.chabaudi model system does
however give us a wealth of experimental data which may help us
Innate Immunity and Malaria
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develop hypotheses for the regulation of potentially more complex
human malaria infections.
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Found at: doi:10.1371/journal.pone.0010444.s001 (0.26 MB
PDF)
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